|Day Low/High||47.71 / 48.68|
|52 Wk Low/High||44.30 / 63.69|
"I would describe today's market action as "benign." And that applies to almost every asset class." -- Kass Diary 104 trading sessions without a one percent drop in the indices. "Don't Think the Machines Could Turn to Selling? You've Forgotten 1987....
"Wishin' and hopin' And thinkin' and prayin'..." -- Dusty Springfield, Wishin' and Hopin' The gap from last week's presidential speech was filled this afternoon. I am more negative than most and more negative than I have been in a while. Liter...
In a 24-week trial of 22 patients, OncoSec saw a 41% response rate
There has been a very narrow trading range and a lack of price movement.
There are nearly too many surging sectors to count.
"Bull markets are born on pessimism, grow on skepticism, mature on optimism and die on euphoria." -- Sir John Templeton DuPont (still on my Best Ideas List) and 3M accounted for 110% of today's gain in the Dow Jones Industrial Average. It was the ...
These may be uncharted waters, but they're not necessarily expensive.
Icahn may have a tough time finding interest in this behemoth.
TheStreet's Jim Cramer comments on Wednesday's most talked about stocks.
Here are 5 things you must know before the market opens Wednesday.
Toll Brothers TOL says the average price of a home it built declined, due to the cost of building materials.
Every single market indicator I look at is overbought. But it's likely that shorts and underperformers are buoying stocks. Some are at the most overbought in decades. The bond market is clearly not as sanguine on economic growth/corporate profi...
Jana Partners are placing three members on Tiffany's board.
I started the day with a discussion of the new administration's policies and why I believe there are headwinds to their passage over the next few months or quarters. I covered last evening's Procter & Gamble short for a profit. "For Traders Only."...
Jim Cramer compares Allergan's growth to other pharma stocks.
Two industries should largely be avoided under this administration: pharma and retail.
"The Dow hit 20,000 and I am proud of it ... Now we have to go up, up, up. It's gone up a lot since I won. We hit a number that has never been hit before. So, I am very honored." --President Donald Trump, ABC interview Wednesday night If the market ...
Bristol-Myers Squibb needs to reorganize itself in what is now a challenging environment, says Jim Cramer.
I am reluctant to call this a breakout, and am willing to sit back and wait.